Nootropics
Selank
A tuftsin-related peptide investigated for anxiety-related effects, with limited human comparative evidence and a broader preclinical literature.
Research explained · evidence varies by outcome
Also known as: tuftsin analog
Practical use
Applying the explained evidence
- Where it fits
- A tuftsin-related peptide investigated for anxiety-related effects, with limited human comparative evidence and a broader preclinical literature.
- Put the information into practice
- The clinical study used an active comparator, medazepam. Similar observed outcomes in a small comparison do not prove equivalence unless the trial was designed and powered for that question. Read the comparator and design, not just a statement that both groups improved.
- Make the claim measurable
- Specify the claimed effect: alertness, memory, attention or another outcome. Check whether researchers measured that outcome directly; a mechanism or a subjective feeling is a different kind of evidence.
- Keep this limit in view
- Small sample; the accessible English abstract provides limited design and long-term safety detail. It does not establish benefit for healthy cognition or broad equivalence with established treatments.
Overview
Selank is a synthetic peptide analog of tuftsin. Its research spans anxiety symptoms, stress biology and experimental behavioral models. The most useful distinction is between a clinical symptom comparison and animal work exploring mechanisms. Calling it a nootropic does not establish a measurable improvement in healthy-person cognition.
Risks and limitations
The small clinical report below does not establish rare adverse-event rates, long-term safety, or safety of combinations with psychiatric medicines or other nootropics. Animal comparisons with sedating medicines are not a basis for replacing prescribed treatment.
How to read this
The clinical study used an active comparator, medazepam. Similar observed outcomes in a small comparison do not prove equivalence unless the trial was designed and powered for that question. Read the comparator and design, not just a statement that both groups improved.
Research explained
Anxiety and neurasthenia comparison
Who was studied
62 patients: 30 received Selank and 32 medazepam; psychometric scales and an enkephalin-related measure were assessed.
What was found
The authors reported similar anxiety-related effects, with additional activating/antiasthenic effects described for Selank.
What it cannot establish
Small sample; the accessible English abstract provides limited design and long-term safety detail. It does not establish benefit for healthy cognition or broad equivalence with established treatments.
Read the original studyMorphine-withdrawal model
Who was studied
Morphine-dependent rats with naloxone-precipitated withdrawal.
What was found
Selank reduced several measured withdrawal signs in this experimental setting.
What it cannot establish
This is an animal model, not a human detoxification study. It must not be converted into advice for opioid withdrawal or medication changes.
Read the original studyChronic restraint stress
Who was studied
Male Wistar rats exposed to restraint stress; colon tissue and stress-related measures examined.
What was found
The researchers reported lower corticosterone and changes in tissue manifestations of stress with Selank.
What it cannot establish
Animal stress models and tissue changes do not establish treatment of a human bowel disorder or anxiety condition.
Read the original studyWhy the mechanism should not be reduced to one slogan
Peptide stress and anxiety research can involve several signaling systems and downstream effects. A change in a biomarker does not prove the cause of a clinical effect. The 2008 report measured an enkephalin-related marker alongside symptoms; that is not the same as demonstrating one exclusive receptor mechanism.
Supporting sourceWhat counts as a useful next study
A larger independently replicated, blinded trial with a clear diagnosis, prespecified outcomes, appropriate control and longer safety follow-up would answer more than additional animal biomarker findings. Claims about healthy cognition would need their own relevant participants and cognitive tests.
Common questions
Is Selank the same as Semax?
No. They are different peptides with different origins and experimental literatures. Their names and common marketing category do not make them interchangeable.
Does a rat withdrawal study establish a treatment for people?
No. It cannot establish clinical effectiveness or a safe management plan for human withdrawal.
Sources
Anxiety and neurasthenia comparison
Sources checked 2026-09-28.
General education; not a personal treatment plan.